(SWL) Versus (ODT) Versus Combined SWL And ODT For Radiolucent Stone
Shockwave Lithotripsy (SWL) Versus Oral Dissolution Therapy (ODT) Versus Combined SWL And ODT For Radiolucent Renal Stone Randomised Controlled Trial
1 other identifier
interventional
150
1 country
1
Brief Summary
compare the efficacy of of ultrasound guided SWL versus dissolution therapy versus combined SWL and dissolution therapy in management of 1 - 2.5 cm renal stones.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2017
CompletedFirst Submitted
Initial submission to the registry
December 23, 2017
CompletedFirst Posted
Study publicly available on registry
January 2, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
March 30, 2018
CompletedAugust 6, 2018
August 1, 2018
12 months
December 23, 2017
August 2, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Stone free rate
Free renal units from stones
3 months
Study Arms (3)
Ultrasound guided SWL
ACTIVE COMPARATORultrasound guided SWL for Radiolucent stone
Dissolution therapy
ACTIVE COMPARATORDissolution therapy for Radiolucent stone
Combined ultrasound guided SWL and dissolution therapy
ACTIVE COMPARATORCombined treatment for Radiolucent stone.
Interventions
Ultrasound guided SWL for radiolucent renal stone
Alkalinization dissolution therapy for radiolucent renal stone
Combined ultrasound guided SWL and alkalinization dissolution therapy for radiolucent renal stone
Eligibility Criteria
You may qualify if:
- Adult patient with 1-2.5 cm renal stones.
- Normal Serum creatinine
- Radiolucent stone by X-ray
You may not qualify if:
- Pregnancy.
- Bleeding diatheses.
- Patients with a pacemaker.
- Uncontrolled UTIs.
- Severe skeletal malformations.
- Severe obesity which prevent targeting of the stone; BMI (40 or more).
- Arterial aneurysm in the vicinity of the stone.
- Anatomical obstruction distal to the stone.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Urology and Nephrology Center
Al Mansurah, Aldakahlia, 35516, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Khalid Sheir, MD
Shock wave unit chief - Urology and nephrology center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
December 23, 2017
First Posted
January 2, 2018
Study Start
April 1, 2017
Primary Completion
March 30, 2018
Study Completion
March 30, 2018
Last Updated
August 6, 2018
Record last verified: 2018-08